[
J Cell Sci,
2016]
The Wnt/-catenin signaling pathway is utilized across metazoans. However, the mechanism of signal transduction, especially dissociation of the -catenin destruction complex by Dishevelled proteins, remains controversial. Here we describe the function of the Dishevelled paralogs DSH-2 and MIG-5 in the Wnt/-catenin Asymmetry (WA) pathway in Caenorhabditis elegans, where WA drives asymmetric cell divisions throughout development. We find that DSH-2 and MIG-5 redundantly regulate cell fate in hypodermal seam cells. Similarly, both DSH-2 and MIG-5 are required for negative regulation of SYS-1/-catenin localization, but MIG-5 has a stronger effect on polarity of SYS-1 localization. We show that MIG-5 controls cortical APR-1/APC localization. DSH-2 and MIG-5 both regulate the localization of WRM-1/-catenin, acting together as negative regulators of WRM-1 nuclear localization. Finally, we demonstrate that overexpression of DSH-2 or MIG-5 in seam cells leads to stabilization of SYS-1 in the anterior seam daughter, solidifying the Dishevelleds as positive regulators of SYS-1/-catenin. Overall, we have further defined the role of Dishevelled in the WA signaling pathway, and demonstrated that DSH-2 and MIG-5 regulate cell fate, -catenin nuclear levels and polarity of -catenin regulation.
[
Exp Gerontol,
2018]
The conserved EGFR pathway is linked with multiple cancers in humans including breast, ovarian, and lung carcinoma. Withanolide A, one of the major withanolidal active compounds isolated from the Withania somnifera, extends lifespan and ameliorates stress resistance in wild-type C. elegans by targeting the Insulin/IGF-1 signaling pathway. Up-regulation of IGF1 can transactivate EGFR which inturn reduces longevity and promotes tumor development in an organism. We examined the effects of Withanolide A on the lifespan of a human EGFR-driven C. elegans transgenic model exhibiting the multivulva (Muv) phenotype. The results showed that WA extends the lifespan of both wild human EGFR-driven C. elegans model (human wild-type tyrosine kinase) as well as models bearing single (L858R), and double mutations (T790M-L858R). The lifespan extension observed in these transgenic strains was 20.35, 24.21 and 21.27%, respectively. Moreover, the reduced fat levels were noticed in both wild-type N2 worms and transgenic strains. These observations support the heathspan promoting effect of WA as lipid-rich diet has been reported to promote tumor development. In view of the fact that most of the well known FDA approved drugs such as gefitinib fail to inhibit the EGFR-associated cancers because of these mutations, the present findings show the potential of Withanolide A as a foreseen future nutraceutical to improve the average survival of cancer patients.